79392996 - BDC

Information

  • Trademark
  • 79392996
  • Serial Number
    79392996
  • Filing Date
    December 19, 2023
    5 months ago
  • Transaction Date
    April 18, 2024
    a month ago
  • Status Date
    April 04, 2024
    2 months ago
  • Location Date
    April 04, 2024
    2 months ago
  • Status Code
    630
  • Current Location
    INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)
  • Owners
Mark Drawing Code
4000
Mark Identification
BDC
Case File Statements
  • GS0051: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease
  • GS0421: Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid
Case File Event Statements
  • 4/18/2024 - a month ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 4/12/2024 - a month ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/4/2024 - 2 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR